Paysign(NASDAQ) PAYS

Paysign, Inc. makes prepaid cards for people to get paid. It helps healthcare companies manage patient drug discounts. Businesses use its cards to give rewards and incentives.

What Does Paysign Do?

• Pharma Industry: Patient affordability solutions and clinical trial payments; generated $14.6 million in revenue for the three-month period ended June 30, 2026.
• Plasma Industry: Payment processing for blood collection centers; generated $13.0 million in revenue for the three-month period ended June 30, 2026.
• Apherion: Life science software for licensing and hosting targeting blood and plasma collection organizations.
• Corporate Incentives: Prepaid cards for employee rewards, gift cards, and consumer rebates.

Expansion into Healthcare

• Acquired the assets of Gamma Innovation LLC in March 2025.
• Launched 51 net pharmaceutical patient affordability programs during the twelve-month period ended June 30, 2026.
• Opened a new customer service contact center in the third quarter of 2025 to support business growth.

The Technology Advantage

The company manages the entire card lifecycle from design and production to 24/7 customer support. Its technology platform provides real-time data analytics and secure transaction processing for diverse industries.

Revenue and Income Growth

• Market capitalization was $536.1 million as of the latest reporting.
• Total revenue was $28.3 million for the three-month period ended June 30, 2026, up 48.1% year over year.
• Net income reached $6.8 million for the three-month period ended June 30, 2026, up 386.9% year over year.
• Available cash was $27.4 million at June 30, 2026, an increase of $15.6 million from the prior-year period.

Final Overview

Paysign has transitioned from a general payment processor to a specialized technology provider for the healthcare sector. This evolution has led to significant growth in high-margin pharmaceutical and plasma industries.